Skip to main content
P

PROTEOMICS INTERNATIONAL LABORATORIES LTD — Investor Relations & Filings

Ticker · PIQ ISIN · AU000000PIQ0 ASX Professional, scientific and technical activities
Open in API
Filings indexed 106 across all filing types
Latest filing 2026-04-27 Investor Presentation
Country AU Australia
Listing ASX PIQ

About PROTEOMICS INTERNATIONAL LABORATORIES LTD

https://www.proteomics.com.au/

Proteomics International Laboratories Ltd specializes in the analysis of protein structures and functions to develop diagnostic tests and therapeutic targets. Utilizing high-resolution mass spectrometry and proprietary bioinformatics, the company identifies biomarkers for various diseases. Its primary commercial product, PromarkerD, is a predictive blood test for diabetic kidney disease that identifies at-risk patients before clinical symptoms manifest. The company also provides contract analytical services to pharmaceutical and biotechnology organizations, supporting drug discovery, biosimilar validation, and clinical trials. By integrating advanced proteomics with clinical data, the firm focuses on the commercialization of precision medicine tools and the improvement of patient management through early detection and monitoring of chronic conditions.

Recent filings

Filing Released Lang Actions
Proteomics Strategic Plan 19 pages 3.2MB
Investor Presentation Classification · 1% confidence The document is a slide‐style presentation dated 28 April 2026 with forward‐looking statements, corporate overview, board profiles, strategy, product pipeline and market analysis. It reads like an investor pitch deck rather than a formal financial report, earnings release or regulatory filing. Therefore it fits the Investor Presentation category.
2026-04-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 565.8KB
Interim / Quarterly Report Q3 2026
2026-04-27 English
Restructure, Executive Appointment and Board Update 2 pages 235.5KB
Board/Management Information Classification · 1% confidence The document is an ASX release announcing organisational restructuring, appointment of a new Chief Financial Officer, and retirement of a board member. It focuses on changes to senior management and the board of directors. This clearly fits the ‘Board/Management Information’ category.
2026-04-16 English
Final Director's Interest Notice 2 pages 305.0KB
Director's Dealing Classification · 1% confidence The document is titled 'Appendix 3Z Final Director's Interest Notice' and details the director’s securities holdings and relevant interests under ASX Listing Rule 3.19A.3. This is a direct report of personal share interests and transactions by a company director, matching the 'Director's Dealing' category.
2026-04-16 English
Appendix 4D and Interim Financial Report 26 pages 1.4MB
Regulatory Filings
2026-02-24 English
Final Director's Interest Notice 3 pages 535.1KB
Regulatory Filings
2026-02-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.